Previous studies have indicated that immune cells are involved in modulating the inflammatory and immune responses in the brain, which may influence the amyloid-beta (Aβ) deposition, tau phosphorylation, neuronal damage, and synaptic dysfunction in AD [42, 43]. The gene discussed is MAPT; the disease is Alzheimer disease.